Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultibro vs Spiriva for Exertional Dyspnea in COPD
NCT02567214Phase 4Completed
- Sponsor
- Université Laval
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Started Jun 2016; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02567214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02567214.